National Bank of Canada
RMD icon

National Bank of Canada’s ResMed RMD Stock Holding History

National Bank of Canada’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8M Buy
137,320
+74,415
+118% +$15.4M 0.02% 475
2026
Q1 		$14.1M Sell
62,905
-33,758
-35% -$8.41M 0.01% 594
2025
Q4 		$23.3M Buy
96,663
+26,816
+38% +$6.86M 0.02% 480
2025
Q3 		$19.1M Sell
69,847
-64,636
-48% -$17.7M 0.02% 511
2025
Q2 		$34.7M Buy
134,483
+44,909
+50% +$10.7M 0.03% 391
2025
Q1 		$20.1M Buy
89,574
+51,453
+135% +$12M 0.02% 517
2024
Q4 		$8.72M Sell
38,121
-28,530
-43% -$6.87M 0.01% 815
2024
Q3 		$16.3M Buy
66,651
+19,120
+40% +$4.27M 0.02% 543
2024
Q2 		$8.88M Buy
47,531
+6,014
+14% +$1.22M 0.01% 593
2024
Q1 		$8.88M Buy
41,517
+3,323
+9% +$609K 0.01% 652
2023
Q4 		$6.56M Buy
38,194
+3,802
+11% +$584K 0.01% 672
2023
Q3 		$5.01M Buy
34,392
+6,893
+25% +$1.25M 0.01% 795
2023
Q2 		$5.91M Buy
27,499
+14,397
+110% +$3.21M 0.01% 673
2023
Q1 		$2.87M Buy
13,102
+5,833
+80% +$1.27M 0.01% 748
2022
Q4 		$1.51M Buy
7,269
+2,943
+68% +$647K ﹤0.01% 948
2022
Q3 		$964K Sell
4,326
-236
-5% -$53.7K 0.01% 991
2022
Q2 		$978K Sell
4,562
-3,042
-40% -$648K ﹤0.01% 1027
2022
Q1 		$1.85M Buy
7,604
+3,328
+78% +$805K 0.01% 899
2021
Q4 		$1.09M Buy
+4,276
New +$1.11M ﹤0.01% 1023

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

National Bank of Canada's RMD Position: Q2 2026 in Review

National Bank of Canada increased its ResMed (RMD) stake by 118% in Q2 2026, buying an estimated $15.4M and bringing the position to 137,320 shares worth $26.8M. The position accounts for 0.02% of the portfolio, ranked #475.

National Bank of Canada first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $34.7M in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • National Bank of Canada held 137,320 shares of ResMed worth $26.8M as of Q2 2026.
  • National Bank of Canada bought 74,415 ResMed shares in Q2 2026, an estimated $15.4M.
  • ResMed made up 0.02% of National Bank of Canada's portfolio in Q2 2026, its #475 holding.
  • National Bank of Canada first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's ResMed position peaked at $34.7M in Q2 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.